News
Archive
NorthSea Therapeutics provides clinical update reflecting progress across NASH and metabolic disorders programmes
Novadip Biosciences SA announces positive results from Phase 1/2 clinical trial in patients with severe bone non-union of the lower limb following trauma
Ventyx Biosciences announces dosing of the first patient in the Phase 2 SERENITY trial of VTX958 for the treatment of moderate to severe plaque psoriasis
Resolve Therapeutics completes enrollment of Phase II Long Covid clinical trial
Novadip Biosciences raises additional EUR 40 Million bringing total company funding to EUR 88 Million
Phase Four unveils game changing engine for LEO Constellations
Back To News

May 11, 2021
Vascular Therapies announces clinical results from its Phase 3 randomized multicenter clinical trial
Vascular Therapies, a privately held biotechnology company is developing Sirogen, a proprietary sirolimus formulation for intraoperative local drug delivery to reduce surgical stenosis in blood vessels. Today the company announced clinical results from its Phase 3 clinical trial in which Sirogen showed encouraging AV fistula outcomes in elderly end-stage renal disease patients.